AlveoliX AG Revenue and Competitors
Estimated Revenue & Valuation
- AlveoliX AG's estimated annual revenue is currently $1.9M per year.
- AlveoliX AG's estimated revenue per employee is $155,000
Employee Data
- AlveoliX AG has 12 Employees.
- AlveoliX AG grew their employee count by -25% last year.
AlveoliX AG's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Products & Clients Manager | Reveal Email/Phone |
AlveoliX AG Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is AlveoliX AG?
Our Vision We aim at changing the way drug development research is done today by providing in-vitro models that reproduce the in-vivo environment in an unprecedented way. These in-vitro models, called organ-on-chips, will make it possible to better predict drugs' responses in humans than standard in-vitro and in-vivo models and as a consequence to importantly reduce animal testing. Our Mission AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AlveoliX AG News
Alveolix AG Lung-on-Chip System zur Verbesserung der Arzneimittelentwicklung: Das Berner Start-up hat sich zum Ziel gesetzt,...
Additionally, we are proud to share in celebrating this achievement with fellow finalists, AlveoliX AG and Biospectal SA,...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 12 | -20% | N/A |
#2 | $1.6M | 13 | -7% | N/A |
#3 | $2.1M | 15 | -57% | N/A |
#4 | $1.2M | 15 | -37% | N/A |
#5 | $1M | 16 | 7% | N/A |
